We don't believe consumers would purchase and repurchase it if it didn't work for them.

Keeping in mind that this is only a recommendation, it doesn't mean the FDA will take this product off the market. We have asked [the FDA] for the opportunity to reformulate the product using a non-CFC propellant, which will take us about five years. We need to reformulate it and put it through clinical trials and then submit it to the FDA as a new drug for evaluation.

It provides an important public health benefit, there's no other OTC alternative to CFC epinephrine inhalers, and the environmental risk from the release of CFCs from Primatene is small and justified given the benefit it provides.

We've gotten the word out. Making it in middle of afternoon makes it tough on our members who must work.

Everybody was wondering, Is it going to work? Is it going to work?

We have much work to do.